5.48 pm | 20 Feb 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended accumulate rating on the stock with a target price of ...

4.58 pm | 20 Feb 2012 |  Source: Moneycontrol.com

Motilal Oswal has maintained neutral rating on Sun Pharma with a target of Rs 614, in its February 15, 2012 research report....

2.01 pm | 20 Feb 2012 |  Source: Moneycontrol.com

PINC Research is bearish on Sun Pharma and has recommended reduce rating on the stock with a target of Rs 534 in its February 16, 2012 research report...

12.08 pm | 16 Feb 2012 |  Source: Moneycontrol.com

PINC Research is bearish on Sun Pharma and has recommended reduce rating on the stock with a target of Rs 534 in its February 13, 2012 research report...

11.35 am | 16 Feb 2012 |  Source: CNBC-TV18

“We strongly believe that we have reasons to disagree with the claim that they have made. Fundamentally, we also believe that the patent invalidated i...

10.56 am | 16 Feb 2012 |  Source: Reuters

Wyeth Pharmaceuticals Inc is seeking USD 960 million in damages from Sun Pharmaceutical Industries for alleged patent infringement in launching a gene...

1.05 pm | 15 Feb 2012 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries has reported a sales turnover of Rs 1,011.85 crore and a net profit of Rs 365.23 crore for the quarter ended Dec '11...

4.12 pm | 13 Feb 2012 |  Source: Reuters

Sun Pharmaceutical Industries, India's top drugmaker by market capitalisation, reported a better-than-expected 91% rise in December quarter net profit...

3.34 pm | 13 Feb 2012 |  Source: Moneycontrol.com

Sun Pharma has announced its third quarter results. The company's Q3 consolidated net profit was up 91% at Rs 668 crore versus Rs 350 crore, year-on-y...

2.00 pm | 13 Feb 2012 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries has declared its third quarter numbers. Its Q3 consolidated net profit was up at Rs 668 crore versus Rs 350 crore, YoY. ...

10.36 am | 11 Feb 2012 |  Source: CNBC-TV18

Sun Pharmaceutical Industries, country's largest drugmaker by market cap, is set to announce its results for the quarter ended December FY12 on Monday...

10.22 am | 07 Feb 2012 |  Source: CNBC-TV18

Indian market is rallying with full might gaining 15% alone in 2012. Experts are hopeful that this rally will continue for some more time. So, till it...

9.59 am | 31 Jan 2012 |  Source: CNBC-TV18

Profit booking after a stellar performance in the last four weeks, has Sudarshan Sukhani of s2analytics telling CNBC-TV18’s viewers that today is one ...

9.13 am | 31 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics is of the view that one can buy Sun Pharma....

11.20 am | 20 Jan 2012 |  Source: CNBC-TV18

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting a...

9.08 am | 20 Jan 2012 |  Source: CNBC-TV18

Buy Sun Pharmaceutical, says Sudarshan Sukhani, s2analytics.com....

8.58 am | 20 Jan 2012 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com spoke to CNBC-TV18 about his expectations of the market now. The Nifty yesterday crossed the 5000 with ease, but ...

8.35 am | 20 Jan 2012 |  Source: CNBC-TV18

On CNBC-TV18's show Super Six, market gurus Arunesh Madan, Founder and Director of Augment Investment Pvt ltd, Nooresh Mirani - AVP Technical, AMSEC R...

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

9.56 am | 13 Jan 2012 |  Source: CNBC-TV18

Anil Manghnani, Modern Shares & Stock Brokers says, 4,860-4,880 is a key resistance for the Nifty. “I wouldn’t want to take a fresh call, unless I see...